Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Cash from Investing Activities (2023 - 2026)

Nexalin Technology (NXL) posted Cash from Investing Activities of $1.5 million for Q2 2026, down 3.27% on a QoQ basis from $1.5 million in Q1 2026, and up 137.25% year-over-year from $615512.2 in Q2 2025.

Analysis

Nexalin Technology (NXL) Cash from Investing Activities (2023 - 2026) Analysis & Trends

Nexalin Technology has reported Cash from Investing Activities for 4 years, with the latest figure at $1.5 million in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities rose 137.25% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $5.3 million, a 199.66% increase from a year earlier, with the FY2025 full-year figure at -$131991.0, up 77.15% from the prior year.
  • Cash from Investing Activities was $1.5 million for Q2 2026 at Nexalin Technology, down from $1.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $1.6 million in Q4 2024, with the low at -$4.5 million in Q3 2024.
  • Average Cash from Investing Activities over 4 years is $479524.8, with a median of $1.3 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2026: Cash from Investing Activities slumped 639.66% in 2024, then surged 137.25% in 2026.
  • Over 4 years, Cash from Investing Activities stood at $1.2 million in 2023, then jumped by 33.09% to $1.6 million in 2024, then plunged by 57.66% to $689180.0 in 2025, then soared by 111.89% to $1.5 million in 2026.
  • The last three Cash from Investing Activities figures came in at $1.5 million (Q2 2026), $1.5 million (Q1 2026), and $689180.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn -1.62 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -193.20 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 329.80 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -108.50 Mn
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00 1.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.46 Mn
Mar 31, 2026 1.51 Mn
Dec 31, 2025 689,180.00
Sep 30, 2025 1.63 Mn
Jun 30, 2025 -3.92 Mn
Mar 31, 2025 1.47 Mn
Dec 31, 2024 1.63 Mn
Sep 30, 2024 -4.48 Mn
Jun 30, 2024 1.55 Mn
Mar 31, 2024 729,314.00
Dec 31, 2023 1.22 Mn
Sep 30, 2023 830,769.00
Jun 30, 2023 872,372.00
Mar 31, 2023 1.53 Mn